Curated News
By: NewsRamp Editorial Staff
July 06, 2026
LataMed AI Begins Expansion into Colombia with Due Diligence
TLDR
- LataMed AI's early due diligence in Colombia positions it to gain a first-mover advantage in Latin America's digital health market.
- LataMed AI evaluates corporate, regulatory, and operational requirements to establish a Colombian subsidiary for digital healthcare platform deployment.
- LataMed AI's expansion into Colombia aims to improve healthcare accessibility and patient engagement in underserved Latin American markets.
- LataMed AI is exploring AI-driven healthcare technologies to transform care coordination in emerging markets like Colombia.
Impact - Why it Matters
This news matters because it signals a strategic move by LataMed AI to expand digital healthcare infrastructure into Colombia, a market with significant underserved populations. If successful, this expansion could improve healthcare accessibility and coordination in the region, leveraging AI and telehealth to address gaps in care. For investors, it highlights the company's growth trajectory in emerging markets, though it remains in early stages with inherent risks.
Summary
LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, has announced the commencement of preliminary due diligence and strategic planning for its expansion into Colombia. The company, which focuses on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, aims to establish a Colombian operating subsidiary to support the deployment of its digital healthcare platform. This initial phase involves evaluating corporate, regulatory, legal, operational, and commercial requirements to ensure a solid foundation for market entry. Management believes Colombia represents an attractive long-term market as part of LataMed's broader Latin American expansion strategy.
The evaluation process will include assessments of corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, local operational infrastructure, and other market entry considerations. The company intends to build upon its growing healthcare ecosystem by identifying opportunities to expand access to telehealth infrastructure, healthcare coordination technologies, digital healthcare services, insurance accessibility initiatives, pharmacy integration opportunities, payment accessibility solutions, and artificial intelligence-driven healthcare technologies across additional Latin American markets. Dr. Kevin Rodan Levy, CEO of LataMed AI Corp., emphasized that Colombia is an important strategic opportunity as the company executes its long-term vision of building an integrated digital healthcare ecosystem in the region. He stated that establishing the proper legal, operational, and strategic foundation is crucial before expanding into new jurisdictions.
The company noted that the expansion initiative remains in the preliminary planning and due diligence stage. Management will complete the required corporate, regulatory, and operational review before proceeding with the establishment of a Colombian subsidiary and expects to provide updates as material developments occur. LataMed AI Corp. is focused on developing technology platforms to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations, with an initial regional focus on Latin America. The original release can be viewed on NEWMEDIAWIRE.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, LataMed AI Begins Expansion into Colombia with Due Diligence
